|
Written by Kaitlyn Dmyterko
ATLANTA—For patients with implanted cardiac devices, MRI has never been a viable way to obtain diagnostic tests due to device contraindications and risks. However, new research has found that MRI testing in this patient population can be performed at little or no risk, Robert H. Helm, MD, from Boston Medical Center, said during a presentation at the American College of Cardiology (ACC) scientific sessions on Monday.
Abbott today settled all outstanding intellectual property litigation with Medtronic. Under the terms of the settlement, Medtronic will pay Abbott $400 million and $42 million to evYsio Medical Devices, based in Vancouver, British Columbia.
Medtronic plans to reduce its global work force by 1,500 to 1,800 employees, in an effort to further align the company with its long-term growth outlook.
Medtronic has requested that the Centers for Medicare & Medicaid Services (CMS) revise national coverage determination for cardiac pacemakers to include coverage for devices that have been designed, tested and FDA labeled for use in the MRI environment.
Medtronic today acquired Ventor Technologies, a developer of transcatheter heart valve technologies for the treatment of aortic valve disease, for a payment of $325 million. The company also signed a definitive agreement today to acquire CoreValve for $700 million, plus additional payments contingent upon the achievement of agreed milestones.
Boston Scientific and Medtronic have settled two lawsuits and signed an agreement to stand down in three others, which will stop all current litigation between the two companies in the fields of interventional cardiology and endovascular repair.
The use of advanced visualization software enables the utilization of coronary CT angiography (CCTA) to accurately depict stent fractures in patients that are not clearly depicted by conventional angiography, according to a study published in the December issue of Radiology.
The U.S. District Court for the District of Colorado has awarded $4.38 million in attorney fees, costs and expenses to BrainLAB in a patent infringement lawsuit brought by Medtronic.
|
Medtronic is partnering with Vital Images to provide imaging and advanced visualization services for endovascular specialists who use Medtronic's portfolio of stent grafts to treat aortic aneurysms.
Medtronic has received the European CE Mark for its second-generation pacemaker for use with MRI machines, the Advisa DR MRI SureScan pacing system.
BOSTON--In the MRI environment under specific guidelines, a new pacemaker system facilitates access to this diagnostic imaging technique with no evidence of clinical (bradycardia or tachycardia), subclinical (pacemaker performance) or technical (pacemaker or lead damage) deficits in patients, according to a late-breaking clinical pivotal trial presented May 14 at the 2009 meeting of the Heart Rhythm Society (HRS).
In a surprise decision, the Supreme Court ruled 6-3 today that Vermont resident, Diana Levine, can sue Wyeth for injuries she suffered after she was administered one of the company's FDA-approved drugs.
Medtronic reported strong growth in profits for the medical device manufacturer's fiscal 2009 third quarter, which ended Jan. 23.
The prevailing notion is that bypass surgery is superior to stenting in patients with diabetes. The truth, however, is more complicated, as the decision-makers learn to examine the individual pathologies in lieu of standardization. Often, this process is more art than science in taking into account all of the parameters of a patient’s disease.
Medtronic has received the European CE Mark for its EnRhythm MRI SureScan pacemaker and CapSureFix MRI SureScan pacing leads designed for use in MRI systems under specified conditions.
Boston Scientific scored a major victory in an ongoing patent dispute
with Medtronic involving balloon catheters and stent delivery systems,
when the judge reduced the award from $250 million to $19 million.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.